Method Development And Validation Of Anti-cancer Drug: Doxorubicin | 6073
ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Method Development and Validation of Anti-cancer Drug: Doxorubicin

International Conference & Exihibition On Analytical and Bioanalytical Techniques - 2010

Jyoutsna Anand, Devendra Phatak

ScientificTracks Abstracts: J Anal Bioanal Techniques

DOI: 10.4172/2155-9872.1000001

Doxorubicin is the one of the most potent antitumor drug of Bone Cancer, Breast cancer. A simple and sensitive HPLC method was developed and validated for the assay of doxorubicin. The method used a column C 18 (250mm*4.6mm) with a UV. Detector is 254nm wavelength. The mobile phase consists of buffer solution (Sodium Lauryl Sulphate & OrthoPhosphoric Acid): Acetonitrile. Flow rate was found 1.0ml/min. All the system suitability parameter was found according to the ICH standards. The method was extensively validated for specificity, linearity, accuracy and precision, recovery robustness. The present assay of drugs was found to be in range.